RiteMED Clarithromycin Indications/Uses

Tablet: For the treatment of the following infections caused by susceptible microorganisms: Upper respiratory tract infections including streptococcal pharyngitis and tonsillitis; acute otitis media and acute maxillary sinusitis; lower respiratory tract infections including atypical pneumonia, bronchitis; skin and skin structure infections including impetigo, folliculitis, cellulitis, abscesses (abscesses usually require surgical drainage).
Disseminated or localized mycobacterial infections due to Mycobacterium intracellulare or Mycobacterium avium. Localized infections due to Mycobacterium kansasii, Mycobacterium chelonae and Mycobacterium fortuitum (usually in combination with other antimicrobial agents).
Helicobacter pylori infections (in combination with other drugs); odontogenic infections.
Suspension: Clarithromycin Granules (clarithromycin for oral suspension, USP) are indicated for the treatment of mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions as listed as follows: Adults (Granules for oral suspension): Pharyngitis/Tonsillitis due to Streptococcus pyogenes (The usual drug of choice in the treatment and prevention of streptococcal infections and the prophylaxis of rheumatic fever is penicillin administered by either the intramuscular or the oral route. Clarithromycin is generally effective in the eradication of S. pyogenes from the nasopharynx; however, data establishing the efficacy of clarithromycin in the subsequent prevention of rheumatic fever are not available at present).
Acute maxillary sinusitis due to Haemophilus influenzae, Moraxella catarrhalis, or Streptococcus pneumoniae. Acute bacterial exacerbation of chronic bronchitis due to Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, or Streptococcus pneumoniae.
Community-Acquired Pneumonia due to Haemophilus influenzae, Mycoplasma pneumoniae, Streptococcus pneumoniae, or Chlamydia pneumoniae (TWAR).
Uncomplicated skin and skin structure infections due to Staphylococcus aureus, or Streptococcus pyogenes (Abscesses usually require surgical drainage).
Disseminated mycobacterial infections due to Mycobacterium avium, or Mycobacterium intracellulare.
Children: Pharyngitis/Tonsillitis due to Streptococcus pyogenes. Community-acquired pneumonia due to Mycoplasma pneumoniae, Streptococcus pneumoniae, or Chlamydia pneumoniae (TWAR). Acute maxillary sinusitis due to Haemophilus influenzae, Moraxella catarrhalis, or Streptococcus pneumoniae. Acute otitis media due to Haemophilus influenzae, Moraxella catarrhalis, or Streptococcus pneumoniae.
Uncomplicated skin and skin structure infections due to Staphylococcus aureus, or Streptococcus pyogenes (Abscesses usually require surgical drainage).
Disseminated mycobacterial infections due to Mycobacterium avium or Mycobacterium intracellulare.
It is given in the treatment of respiratory tract infections (including otitis media) and in skin and soft tissue infections. It is also used for the prophylaxis and treatment of opportunistic mycobacterial infections. And has been used for the treatment of leprosy. It may also be given to eradicate Helicobacter pylori in treatment regimens for peptic ulcer disease.